If this email is not displaying properly or to share with a colleague, please
View as Webpage
|
|
Homelessness and Substance Use During the COVID-19 Pandemic: A Guide for Primary Care Providers
|
|
The homeless population is particularly vulnerable during the COVID-19 pandemic. Some substances repress respiration, which could worsen respiratory function in those who contract the virus. Drs. Elizabeth M. Moore, Sae Takada, Roya Ijadi-Maghsoodi, Lillian Gelberg of UCLA have created a guide for PCSS for primary care providers on the treatment of substance use disorders during COVID-19.
[Access guide]
|
|
Find more COVID-19 Resources
here
.
|
|
PCSS Clinical Roundtables and Trainings
|
|
Upcoming PCSS Clinical Roundtables
|
|
Credit Designations Available:
AMA PRA Category 1 Credit™, and Interprofessional Continuing Education (IPCE) credit.
* All times are EDT
|
|
National Council for Behavioral Health
Treatment and Engagement Strategies for Youth
and Young Adults with Opioid Use Disorder (OUD)
Date: May 28, 2020
Time: 2:00 pm - 3:00 pm EDT
Presenter: J. Craig Allen, MD, FASAM, Medical Director, Rushford, Chief of Psychiatry, Midsta, Assistant Professor of Psychiatry, University of Connecticut School of Medicine, Associate Professor of Psychiatry; Frank H. Netter School of Medicine, Quinnipiac University
Target Audience: This activity is designed to meet the needs of primary care physicians, specialty care physicians, psychiatrists, allied professional staff, program administrators, staff specializing in adolescent services.
Webinar Description: Adolescents and young adults are one-tenth as likely to get appropriate treatment for opioid use disorder (OUD) than those over the age of 25. Medications for opioid use disorder (MOUD), considered first line treatments, decrease the risk of overdose death from 50-80%.
[Learn more]
|
|
The National Judicial College
Medications for Alcohol and Drug Use Disorders 101: The Science of Medication Treatment
Date: June 9, 2020
Time: 1:00 pm - 2:00 pm EDT
Presenter: Joshua D. Lee, MD, MSc, Associate Professor of Population Health and Medicine/General Internal Medicine and Clinical Innovation at the NYU School of Medicine
Target audience: This webcast was developed for judges—whether presiding over state, municipal, general jurisdiction, treatment/specialty courts and/or whether they are law trained or not.
About the webinar: Alcohol and drug use disorders are associated with criminal behavior, arrest, and incarceration. Effective treatments are needed to reduce the burden of alcohol and drug use disorders on public safety and on the public health. Fortunately, there are three medications (antabuse, acamprosate, and naltrexone) that are FDA-approved for the treatment of alcohol dependence and three medications (methadone, buprenorphine, and naltrexone) that are approved for the treatment of opiate dependence.
[Learn more]
|
|
The Following Webinar Recordings Are Now Available:
(American Academy of Addiction Psychiatry from May 19)
|
|
The
2020 National Health Service Corps (NHSC) New Site Application cycle is now open for eligible health care sites and will close on Tuesday, July 21 at 11:59 p.m. ET.
The
Evidence-based Practice Center (EPC) Program at the Agency for Healthcare Research and Quality (AHRQ) has posted the draft technical brief on Prevention, Diagnosis, and Management of Opioids, Opioid Misuse and Opioid Use Disorder in Older Adults. It is available for your review and feedback until June 12 at the Effective Healthcare Web site. The purpose of the review is to provide a framework for understanding how to reduce adverse outcomes of opioid use among older adults and to describe the evidence available for different factors associated with and interventions to reduce adverse outcomes related to opioid use in this population.
[Learn more]
ADA News
The American Journal on Addictions
American Journal of Public Health
Journal of Substance Abuse Treatment
NIDA News
Pain Medicine
*Requires subscription
|
|
Funding for this initiative was made possible (in part) by grant no.
1H79TI081968
from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
|
|
|
|
|
|
|
